Basics Nuvalent, Inc. IPO Date: July 29, 2021 Sector: Healthcare Industry: Biotech Market Cap: $5.83B Activated in VL: True Average Daily Range Avg Daily Range: $1.20 | 3.01% Avg Daily Range (30 D): $1.16 | 1.52% Avg Daily Range (90 D): $1.50 | 1.96% Institutional Daily Volume Avg Daily Volume: .29M Avg Daily Volume (30 D): .36M Avg Daily Volume (90 D): .39M Trade Size Avg Trade Size (Sh.): 48 Avg Trade Size (Sh.) (30 D): 41 Avg Trade Size (Sh.) (90 D): 44 Institutional Trades Total Inst.Trades: 1,760 Avg Inst. Trade: $3M Avg Inst. Trade (30 D): $3.55M Avg Inst. Trade (90 D): $3.76M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.62M Avg Closing Trade (30 D): $6.07M Avg Closing Trade (90 D): $6.46M Avg Closing Volume: 71.44K     News Aug 7, 2025 @ 12:18 PM Nuvalent (NUVL) Q2 R&D Up 65% Source: Jesterai Sep 16, 2024 @ 5:44 PM Nuvalent Stock Jumps On ESMO Data Presentation, Se... Source: Vandana Singh May 8, 2024 @ 2:21 PM Why Earnings Season Could Be Great for Nuvalent (N... Source: Zacks Equity Research Oct 17, 2023 @ 10:27 PM Why Nuvalent Stock Tanked on Tuesday Source: newsfeedback@fool.com (Eric Volkman) Oct 6, 2023 @ 3:05 PM Benzinga's 'Stock Whisper' Index: 5 Stocks Investo... Source: Chris Katje Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.39 $-1.18 $-1.06 Diluted EPS $-1.39 $-1.18 $-1.06 Revenue $ M $ M $ -25.3M Gross Profit $ $ $ Net Income / Loss $ -99.65M $ -84.58M $ -74.76M Operating Income / Loss $ -104.57M $ -94.81M $ -86.3M Cost of Revenue $ $ $ Net Cash Flow $ 6.64M $ -24.86M $ -223.55M PE Ratio     Splits Mar 10, 2017:   1:1200000